This inventor holds 27 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica, Other. Active years: 1982-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Turnhout, BE (1984 - 1990)
- Turnhoutseweg 30 Beerse, BE (2001)
- Oud-Turnhout, BE (1982 - 2018)
Company Filing History:
25 out of 2,101 
1 out of 32 
1 out of 834,570 Years Active: 1982-2018
Areas of Expertise:
Title: Josephus Carolus Mertens: A Pioneer in PARP Inhibitors
Introduction
Josephus Carolus Mertens, based in Oud-Turnhout, Belgium, is a distinguished inventor recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of 27 patents, Mertens has focused his efforts on innovative chemical compounds, particularly in the realm of cancer treatment.
Latest Patents
Among Mertens' latest patents are the inventions related to quinazolinone derivatives as PARP inhibitors. These compounds, represented in the patent by formula (I), demonstrate substantial potential in therapeutic applications as PARP inhibitors. The invention emphasizes not only the compounds themselves but also their utility in pharmaceutical compositions, where the components R, R, R, L, X, Y, and Z are defined with careful specificity.
Career Highlights
Mertens has had an impactful career, working primarily with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, known for its commitment to innovation in the healthcare sector. His research and development work have contributed significantly to advancing medical therapies.
Collaborations
Throughout his career, Josephus Carolus Mertens has collaborated with notable colleagues, including Ludo E Kennis and Ludo Edmond Josephine Kennis. Their combined expertise has propelled advancements in the field and facilitated the development of groundbreaking pharmaceutical solutions.
Conclusion
Josephus Carolus Mertens exemplifies the spirit of innovation in the pharmaceutical industry. With a strong focus on developing compounds that inhibit PARP, he is at the forefront of research that may lead to novel treatments for cancer and other diseases. His work continues to inspire future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile